Humalog Mix is a premixed suspension consisting of insulin lispro (fast-acting human insulin analogue) and insulin lispro protamine suspension (intermediate acting human insulin analogue). Humalog Mix is available as pre-filled pen and suspension for injection.
It is available in two strengths Humalog Mix-25 and Humalog Mix-50.
Humalog Mix-25 contains insulin lispro 25% + insulin lispro protamine 75%.
Humalog Mix-50 contains insulin lispro 50% + insulin lispro protamine 50%.
Humalog Mix is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.Insulin lispro has a rapid onset of action (approximately 15 minutes), hence it can be given closer to a meal (within zero to 15 minutes of the meal). One unit of insulin lispro has been shown to be as potent as one unit of human insulin in lowering glucose.
Insulin lispro protamine is an intermediate acting insulin enabling blood glucose control for longer duration, also during night time.
These two in combination provide 24-h coverage and the control of post-meal glucose concentration while limiting the number of daily injections.
Humalog Mix is a brand of Eli Lilly and Company, a global, research-based company founded in 1876. For more than 140 years, Eli Lilly & Company has discovered, developed and acquired innovative new medicines that address key unmet medical needs worldwide. It has remained dedicated to creating medicines that help improve peoples’ quality of life.
Since inception, Lilly India is offering advanced treatment options to treat chronic diseases such as diabetes, lung cancer, gastric cancer, osteoporosis, men’s health and growth-hormone deficiency.